Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery

Interactive Cardiovascular and Thoracic Surgery

Volumn 7, Issue 3, 2008, Pages 452-456

  Mastoraki, Aikaterini ^a,b   Kriaras, Ioannis ^a   Douka, Evangelia ^a   Mastoraki, Sotiria ^a   Stravopodis, Georgios ^a   Geroulanos, Stefanos ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b NONE   (Greece)

Author keywords

Cardiac surgery; MRSA; Preventing strategy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CEFUROXIME; LINEZOLID; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; CARDIOVASCULAR SURGERY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DISEASE CARRIER; DISEASE SEVERITY; ENDOCARDITIS; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDIASTINITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOSE SMEAR; OBSERVATIONAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SCREENING; SEPSIS; SINGLE DRUG DOSE; STAPHYLOCOCCUS INFECTION; STERNUM; SURGICAL DRAINAGE; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE; TRACHEA MUCUS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; CARRIER STATE; CHILD; CROSS INFECTION; DEBRIDEMENT; FEMALE; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; METHICILLIN RESISTANCE; NASAL CAVITY; PATIENT ISOLATION; PROGRAM EVALUATION; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; TIME FACTORS; VIRULENCE;

EID: 44449108154     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.176156     Document Type: Article

References (25)

1. Voss A, Milatovic D, Wallrauch-Schwartz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-55.
2. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003;9:1179-1186.
3. Fluit AC, Wielders CLC, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus from 25 university hospitals participating in the European SENTRY Study. J Clin Microbiol 2001;39:3727-3732.
4. Lin CH, Hsu RB, Chang SC, Lin FY, Chu SH. Poststernotomy mediastinitis due to methicillin-resistant Staphylococcus aureus endemic in a hospital. Clin Infect Dis 2003;37:679-684.
5. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 2001;32:877-883.
6. Lucet JC, Paoletti X, Lolom I, Panqam-Burtz C, Trouillet JL, Timsit JF, Deblanqy C, Andremont A, Requier B. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051-1057.
7. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Jones RN, Beach M. Survey of infections due to Staphylococcus species: frequency of occcurrence and antimicrobial susceptibility of isolated collected in the United States, Canada, Latin America, Europe, and Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32:S114-S132.
8. Oliveira D, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180-189.
9. Musser JM, Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30:2058-2063.
10. Enright M, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687-7692.
11. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001;32:108-115.
12. Mohan SS, McDermott BP, Cunha BA. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 2005;34:69-71.
13. Cassone M, Campanile F, Pantosti A, Venditti M, Stefani S. Identification of a variant 'Rome clone' of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit. Microb Drug Resist 2004;10:43-49.
14. Hirata N, Hatsuoka S, Amemiya A, Ueno T, Kosakai Y. New strategy for treatment of MRSA mediastinitis: one-stage procedure for omental transposition and closed irrigation. Ann Thorac Surg 2003;76:2104-2106.
15. Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG, Sexton DJ, Kaye KS. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004;38:1555-1560.
16. Toumpoulis I, Anagnostopoulos C, DeRose J, Swistel D. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 2005;127:464-471.
17. Taylor M, Napolitano L. Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. Surgical Infections 2004;5:180-187.
18. Nasim A, Thompson MM, Naylor AR, Bell PR, London NJ. The impact of MRSA on vascular surgery. Eur J Endovasc Surg 2001;22:211-214.
19. Grimble SA, Magee TR, Galland RB. Methicillin resistant Staphylococcus aureus in patients undergoing major amputation. Eur J Vasc Endovasc Surg 2001;22:215-218.
20. Harbarth S, Martin Y, Rohner P, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;36:43-49.
21. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-550.
22. Cox RA, Conquest C, Mallaghan C, Marples RR. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 1995;29:87-106.
23. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386.
24. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, doble-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.
25. Schelenz S, Tucker D, Georgiou C, Daly S, Hill M, Roxburgh J, French GL. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control program. J Hosp Infect 2005;60:104-110.